Company Filing History:
Years Active: 2016-2021
Title: Rolf Daniels: Innovator in Oral Dosage Forms and Foam Formulations
Introduction
Rolf Daniels is a notable inventor based in Rottenburg a.N., Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in oral dosage forms and foam formulations. With a total of 2 patents, his work has the potential to impact the delivery of active substances in innovative ways.
Latest Patents
Daniels' latest patents include an invention focused on oral dosage forms. This invention pertains to a mucoadhesive active composition and a corresponding mucoadhesive dosage form, specifically designed to deliver active substances within the oral cavity. One of the key applications is an orodispersible tablet aimed at delivering probiotic substances. Additionally, the invention encompasses methods for producing this composition and processing it into a mucoadhesive dosage form. Another significant patent involves emulsifier-free, polymer-stabilized foam formulations. This invention describes a foam formulation that consists of a substantially emulsifier-free emulsion of the oil-in-water type, which includes an oil phase and an aqueous phase. The formulation features at least one surface-active ionic polymer with a molecular weight exceeding 5000 g/mol, which is a copolymer made from ionic and other monomer units.
Career Highlights
Throughout his career, Rolf Daniels has worked with prominent companies such as Symrise AG and Neubourg Skin Care GmbH & Co. KG. His experience in these organizations has allowed him to refine his expertise in formulation science and innovation.
Collaborations
Daniels has collaborated with notable colleagues, including Anja Hoffmann and Marcus Rudolf Götz. These partnerships have likely contributed to the development and success of his innovative projects.
Conclusion
Rolf Daniels stands out as an inventor whose work in oral dosage forms and foam formulations showcases his commitment to advancing pharmaceutical technology. His patents reflect a deep understanding of formulation science and a drive to improve the delivery of active substances.